Lewis Stanford Seiden - Publications

Affiliations: 
University of Chicago, Chicago, IL 
Area:
Psychopharmacology
Website:
http://www-news.uchicago.edu/releases/07/070730.seiden.shtml

71 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2005 O'Donnell JM, Marek GJ, Seiden LS. Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule. Neuroscience and Biobehavioral Reviews. 29: 785-98. PMID 15893376 DOI: 10.1016/j.neubiorev.2005.03.018  0.659
2001 Seiden LS, Lew R, Malberg JE. Neurotoxicity of methamphetamine and methylenedioxymethamphetamine. Neurotoxicity Research. 3: 101-16. PMID 15111264 DOI: 10.1007/BF03033233  0.679
1999 Sokolowski JD, Seiden LS. The behavioral effects of sertraline, fluoxetine, and paroxetine differ on the differential-reinforcement-of-low-rate 72-second operant schedule in the rat. Psychopharmacology. 147: 153-61. PMID 10591882 DOI: 10.1007/S002130051155  0.352
1999 Jolly DC, Richards JB, Seiden LS. Serotonergic mediation of DRL 72s behavior: receptor subtype involvement in a behavioral screen for antidepressant drugs. Biological Psychiatry. 45: 1151-62. PMID 10331107 DOI: 10.1016/S0006-3223(98)00014-6  0.516
1998 Malberg JE, Seiden LS. Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 5086-94. PMID 9634574 DOI: 10.1523/Jneurosci.18-13-05086.1998  0.707
1998 Malberg JE, Seiden LS. Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat The Journal of Neuroscience. 18: 5086-5094. DOI: 10.1523/JNEUROSCI.18-13-05086.1998  0.688
1997 Borsini F, Cesana R, Kelly J, Leonard BE, McNamara M, Richards J, Seiden L. BIMT 17: a putative antidepressant with a fast onset of action? Psychopharmacology. 134: 378-86. PMID 9452180 DOI: 10.1007/S002130050474  0.575
1997 Balcells-Olivero M, Richards JB, Seiden LS. Sensitization to amphetamine on the differential-reinforcement-of-low-rate 72-s schedule. Psychopharmacology. 133: 207-13. PMID 9361325 DOI: 10.1007/S002130050393  0.459
1997 Malberg JE, Seiden LS. Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles. Brain Research. 765: 101-7. PMID 9310399 DOI: 10.1016/S0006-8993(97)00517-9  0.717
1997 Mukherjee J, Yang ZY, Lew R, Brown T, Kronmal S, Cooper MD, Seiden LS. Evaluation of d-amphetamine effects on the binding of dopamine D-2 receptor radioligand, 18F-fallypride in nonhuman primates using positron emission tomography. Synapse (New York, N.Y.). 27: 1-13. PMID 9268060 DOI: 10.1002/(SICI)1098-2396(199709)27:1<1::AID-SYN1>3.0.CO;2-9  0.322
1997 Richards JB, Mitchell SH, de Wit H, Seiden LS. Determination of discount functions in rats with an adjusting-amount procedure. Journal of the Experimental Analysis of Behavior. 67: 353-66. PMID 9163939 DOI: 10.1901/Jeab.1997.67-353  0.535
1997 Lew R, Weisenberg B, Vosmer G, Seiden LS. Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields. Synapse (New York, N.Y.). 26: 36-45. PMID 9097403 DOI: 10.1002/(SICI)1098-2396(199705)26:1<36::AID-SYN4>3.0.CO;2-F  0.332
1996 Lew R, Sabol KE, Chou C, Vosmer GL, Richards J, Seiden LS. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies. The Journal of Pharmacology and Experimental Therapeutics. 276: 855-65. PMID 8632359  0.459
1996 Sabol KE, Lew R, Richards JB, Vosmer GL, Seiden LS. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations. The Journal of Pharmacology and Experimental Therapeutics. 276: 846-54. PMID 8632358  0.459
1995 Sabol KE, Richards JB, Layton K, Seiden LS. Amphetamine analogs have differential effects on DRL 36-s schedule performance. Psychopharmacology. 121: 57-65. PMID 8539341 DOI: 10.1007/Bf02245591  0.516
1994 Richards JB, Sabol KE, Hand TH, Jolly DC, Marek GJ, Seiden LS. Buspirone, gepirone, ipsapirone, and zalospirone have distinct effects on the differential-reinforcement-of-low-rate 72-s schedule when compared with 5-HTP and diazepam. Psychopharmacology. 114: 39-46. PMID 7846206 DOI: 10.1007/Bf02245442  0.523
1994 Bergmann BM, Seiden LS, Landis CA, Gilliland MA, Rechtschaffen A. Sleep deprivation in the rat: XVIII. Regional brain levels of monoamines and their metabolites. Sleep. 17: 583-9. PMID 7531362 DOI: 10.1093/Sleep/17.7.583  0.313
1993 Marek GJ, Heffner TG, Richards JB, Shaughnessy RA, Li AA, Seiden LS. Effects of caffeine and PD 116,600 on the differential-reinforcement-of-low rate 72-S (DRL 72-S) schedule of reinforcement. Pharmacology, Biochemistry, and Behavior. 45: 987-90. PMID 8415842 DOI: 10.1016/0091-3057(93)90153-K  0.537
1993 Richards JB, Sabol KE, Seiden LS. DRL interresponse-time distributions: quantification by peak deviation analysis. Journal of the Experimental Analysis of Behavior. 60: 361-85. PMID 8409824 DOI: 10.1901/Jeab.1993.60-361  0.516
1993 Richards JB, Baggott MJ, Sabol KE, Seiden LS. A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task. Brain Research. 627: 254-60. PMID 8298969 DOI: 10.1016/0006-8993(93)90328-K  0.761
1993 Richards JB, Sabol KE, Seiden LS. Fluoxetine prevents the disruptive effects of fenfluramine on differential-reinforcement-of-low-rate 72-second schedule performance. The Journal of Pharmacology and Experimental Therapeutics. 267: 1256-63. PMID 8263788  0.459
1993 Dunn RT, Richards JB, Seiden LS. Effects of salbutamol upon performance on an operant screen for antidepressants. Psychopharmacology. 113: 1-10. PMID 7862813 DOI: 10.1007/Bf02244325  0.537
1992 Sabol KE, Richards JB, Seiden LS. Fenfluramine-induced increases in extracellular hippocampal serotonin are progressively attenuated in vivo during a four-day fenfluramine regimen in rats. Brain Research. 571: 64-72. PMID 1611495 DOI: 10.1016/0006-8993(92)90509-8  0.516
1992 Sabol KE, Richards JB, Seiden LS. Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Research. 585: 421-4. PMID 1511330 DOI: 10.1016/0006-8993(92)91249-E  0.516
1992 Sabol KE, Richards JB, Seiden LS. The NMDA receptor antagonist MK-801 does not protect against serotonin depletions caused by high doses of DL-fenfluramine. Brain Research. 582: 129-33. PMID 1386771 DOI: 10.1016/0006-8993(92)90326-5  0.516
1992 SABOL KE, RICHARDS JB, SEIDEN LS. MK801 ENHANCES THE SEROTONIN DEPLETIONS INDUCED BY FENFLURAMINE Behavioural Pharmacology. 3: 66. DOI: 10.1097/00008877-199204001-00205  0.459
1992 RICHARDS JB, SABOL KE, SEIDEN LS. BEHAVIORAL MECHANISM OF THE EFFECTS OF DESIPRAMINE ON THE DRL 72-S ANTIDEPRESSANT SCREEN Behavioural Pharmacology. 3: 50. DOI: 10.1097/00008877-199204001-00153  0.459
1991 Hand TH, Marek GJ, Seiden LS. Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity. Psychopharmacology. 105: 453-8. PMID 1771213 DOI: 10.1007/BF02244363  0.333
1991 Richards JB, Seiden LS. A quantitative interresponse-time analysis of DRL performance differentiates similar effects of the antidepressant desipramine and the novel anxiolytic gepirone. Journal of the Experimental Analysis of Behavior. 56: 173-92. PMID 1683359 DOI: 10.1901/Jeab.1991.56-173  0.516
1990 Li AA, Marek GJ, Hand TH, Seiden LS. Antidepressant-like effects of trazodone on a behavioral screen are mediated by trazodone, not the metabolite m-chlorophenylpiperazine. European Journal of Pharmacology. 177: 137-44. PMID 2311675 DOI: 10.1016/0014-2999(90)90263-6  0.324
1989 Li AA, Marek GJ, Vosmer G, Seiden LS. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats. Pharmacology, Biochemistry, and Behavior. 33: 641-8. PMID 2573905 DOI: 10.1016/0091-3057(89)90402-4  0.419
1988 Kleven MS, Schuster CR, Seiden LS. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. The Journal of Pharmacology and Experimental Therapeutics. 246: 822-8. PMID 2458447  0.454
1988 Kleven M, Woolverton W, Schuster C, Seiden L. Behavioral and neurochemical effects of repeated or continuous exposure to cocaine. Nida Research Monograph. 81: 86-93. PMID 2457161  0.454
1987 Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. The Journal of Pharmacology and Experimental Therapeutics. 241: 338-45. PMID 2883295  0.454
1986 Schuster CR, Lewis M, Seiden LS. Fenfluramine: neurotoxicity. Psychopharmacology Bulletin. 22: 148-51. PMID 3726061  0.454
1986 Woolverton WL, Johanson CE, de la Garza R, Ellis S, Seiden LS, Schuster CR. Behavioral and neurochemical evaluation of phenylpropanolamine. The Journal of Pharmacology and Experimental Therapeutics. 237: 926-30. PMID 3712285  0.454
1985 Preston KL, Schuster CR, Seiden LS. Methamphetamine, physostigmine, atropine and mecamylamine: effects on force lever performance. Pharmacology, Biochemistry, and Behavior. 23: 781-8. PMID 4080764 DOI: 10.1016/0091-3057(85)90072-3  0.563
1985 Ricaurte G, Bryan G, Strauss L, Seiden L, Schuster C. Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals Science. 229: 986-988. PMID 4023719 DOI: 10.1126/Science.4023719  0.454
1985 Ando K, Johanson CE, Seiden LS, Schuster CR. Sensitivity changes to dopaminergic agents in fine motor control of rhesus monkeys after repeated methamphetamine administration. Pharmacology, Biochemistry, and Behavior. 22: 737-43. PMID 4011634 DOI: 10.1016/0091-3057(85)90522-2  0.511
1985 O'Donnell JM, Seiden LS. Effect of the experimental antidepressant AHR-9377 on performance during differential reinforcement of low response rate. Psychopharmacology. 87: 283-5. PMID 3936083 DOI: 10.1007/BF00432708  0.32
1985 Preston KL, Wagner GC, Schuster CR, Seiden LS. Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain. Brain Research. 338: 243-8. PMID 2411342 DOI: 10.1016/0006-8993(85)90153-2  0.695
1984 Ricaurte GA, Seiden LS, Schuster CR. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Research. 303: 359-64. PMID 6744029 DOI: 10.1016/0006-8993(84)91221-6  0.454
1984 Preston KL, Wagner GC, Seiden LS, Schuster CR. Effects of methamphetamine on atropine-induced conditioned gustatory avoidance. Pharmacology, Biochemistry, and Behavior. 20: 601-7. PMID 6728875 DOI: 10.1016/0091-3057(84)90310-1  0.693
1984 Ricaurte GA, Guillery RW, Seiden LS, Schuster CR. Nerve terminal degeneration after a single injection of D-amphetamine in iprindole-treated rats: relation to selective long-lasting dopamine depletion. Brain Research. 291: 378-82. PMID 6697198 DOI: 10.1016/0006-8993(84)91273-3  0.549
1983 Wagner GC, Lucot JB, Schuster CR, Seiden LS. Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes. Brain Research. 270: 285-8. PMID 6883096 DOI: 10.1016/0006-8993(83)90602-9  0.707
1983 Ricaurte GA, Seiden LS, Schuster CR. Increased dopamine metabolism in the rat neostriatum after toxic doses of d-methylamphetamine. Neuropharmacology. 22: 1383-8. PMID 6664467 DOI: 10.1016/0028-3908(83)90228-9  0.454
1983 Ricaurte GA, Fuller RW, Perry KW, Seiden LS, Schuster CR. Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine. Neuropharmacology. 22: 1165-9. PMID 6606137 DOI: 10.1016/0028-3908(83)90075-8  0.454
1982 Wagner GC, Preston K, Ricaurte GA, Schuster CR, Seiden LS. Neurochemical similarities between d,l-cathinone and d-amphetamine. Drug and Alcohol Dependence. 9: 279-84. PMID 7128450 DOI: 10.1016/0376-8716(82)90067-9  0.675
1982 O'Donnell JM, Seiden LS. Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rate. Psychopharmacology. 78: 214-8. PMID 6818577 DOI: 10.1007/BF00428153  0.32
1982 Lucot JB, Wagner GC, Schuster CR, Seiden LS. Decreased sensitivity of rat pups to long-lasting dopamine and serotonin depletions produced by methylamphetamine. Brain Research. 247: 181-3. PMID 6812856 DOI: 10.1016/0006-8993(82)91047-2  0.706
1982 O'Donnell JM, Rider DP, Somani S, Seiden LS. The effect of repeated desipramine administration on water intake in rats. Psychopharmacology. 77: 129-33. PMID 6812130 DOI: 10.1007/BF00431934  0.359
1982 Finnegan KT, Ricaurte G, Seiden LS, Schuster CR. Altered sensitivity to d-methylamphetamine, apomorphine, and haloperidol in rhesus monkeys depleted of caudate dopamine by repeated administration of d-methylamphetamine. Psychopharmacology. 77: 43-52. PMID 6812118 DOI: 10.1007/BF00436098  0.454
1982 Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Research. 235: 93-103. PMID 6145488 DOI: 10.1016/0006-8993(82)90198-6  0.546
1981 Wagner GC, Foltin RW, Seiden LS, Schuster CR. Dopamine depletion by 6-hydroxydopamine prevents conditioned taste aversion induced by methylamphetamine but not lithium chloride. Pharmacology, Biochemistry, and Behavior. 14: 85-8. PMID 7465611 DOI: 10.1016/0091-3057(81)90107-6  0.683
1981 Bittner SE, Wagner GC, Aigner TG, Seiden LS. Effects of a high-dose treatment of methamphetamine on caudate dopamine and anorexia in rats. Pharmacology, Biochemistry, and Behavior. 14: 481-6. PMID 6940202 DOI: 10.1016/0091-3057(81)90306-3  0.604
1981 Wagner GC, Lucot JB, Schuster CR, Seiden LS. The ontogeny of aggregation-enhanced toxicity. Psychopharmacology. 75: 92-3. PMID 6795666 DOI: 10.1007/BF00433509  0.677
1981 Wagner GC, Schuster CR, Seiden LS. Neurochemical consequences following administration of CNS stimulants to the neonatal rat. Pharmacology, Biochemistry, and Behavior. 14: 117-9. PMID 6110209 DOI: 10.1016/0091-3057(81)90113-1  0.711
1980 Lucot JB, Wagner GC, Schuster CR, Seiden LS. The effects of dopaminergic agents on the locomotor activity of rats after high doses of methylamphetamine. Pharmacology, Biochemistry, and Behavior. 13: 409-13. PMID 7422696 DOI: 10.1016/0091-3057(80)90247-6  0.7
1980 Ricaurte GA, Schuster CR, Seiden LS. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Research. 193: 153-63. PMID 7378814 DOI: 10.1016/0006-8993(80)90952-X  0.511
1980 Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Research. 181: 151-60. PMID 7350950 DOI: 10.1016/0006-8993(80)91265-2  0.786
1980 Wagner GC, Ricaurte GA, Johanson CE, Schuster CR, Seiden LS. Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology. 30: 547-50. PMID 6768005 DOI: 10.1212/Wnl.30.5.547  0.511
1979 Seiden LS, Andresen J, MacPhail RC. Methylphenidate and d-amphetamine: effects and interactions with alphamethyltyrosine and tetrabenazine on DRL performance in rats. Pharmacology, Biochemistry, and Behavior. 10: 577-84. PMID 572553 DOI: 10.1016/0091-3057(79)90236-3  0.355
1979 Wagner GC, Seiden LS, Schuster CR. Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs. Drug and Alcohol Dependence. 4: 435-8. PMID 510182 DOI: 10.1016/0376-8716(79)90076-0  0.706
1979 Johanson CE, Aigner TG, Seiden LS, Schuster CR. The effects of methamphetamine on fine motor control in rhesus monkeys. Pharmacology, Biochemistry, and Behavior. 11: 273-8. PMID 116246 DOI: 10.1016/0091-3057(79)90134-5  0.511
1979 Wagner GC, Aigner TG, Seiden LS, Schuster CR. Long-term dopamine depletions and behavioral consequences following treatment with methamphetamine Federation Proceedings. 38: No.3312.  0.454
1978 Johanson CE, Schuster CR, Aigner T, Seiden LS. Effects of methamphetamine and haloperidol on fine motor control before and after repeated injections of methamphetamine Federation Proceedings. 37: No.329.  0.454
1976 Seiden LS, Fischman MW, Schuster CR. Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug and Alcohol Dependence. 1: 215-9. PMID 828106 DOI: 10.1016/0376-8716(76)90030-2  0.511
1966 Killam KF, Killam EK, Seiden LS. The interaction of injected reserpine and dihydroxyphenylalanine or D-amphetamine on electrophysiological and behavioral responses in a conditioned approach situation in the cat. Shinkei Kenkyå« No Shimpo. Advances in Neurological Sciences. 10: 305-6. PMID 6010310  0.55
1964 SEIDEN LS, CARLSSON A. BRAIN AND HEART CATECHOLAMINE LEVELS AFTER L-DOPA ADMINISTRATION IN RESERPINE TREATED MICE: CORRELATIONS WITH A CONDITIONED AVOIDANCE RESPONSE. Psychopharmacologia. 5: 178-81. PMID 14138753 DOI: 10.1007/BF00413240  0.486
1963 SEIDEN LS, CARLSSON A. TEMPORARY AND PARTIAL ANTAGONISM BY L-DOPA OF RESERPINE-INDUCED SUPPRESSION OF A CONDITIONED AVOIDANCE RESPONSE. Psychopharmacologia. 4: 418-23. PMID 14048562 DOI: 10.1007/BF00403346  0.501
1962 SEIDEN LS, WESTLEY J. Partial purification of monoamine oxidase from rat brain. Biochimica Et Biophysica Acta. 58: 363-4. PMID 13910292 DOI: 10.1016/0006-3002(62)91026-0  0.692
Show low-probability matches.